KSRPO asks government to bring in centralised drug enforcement department
Highlights need for uniformity in designations and functioning mechanisms of all state FDAs
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pfizer and BioNTech to potentially supply EU with 200 mn doses of COVID-19 vaccine candidate
The proposed agreement also has an option to purchase additional 100 million doses, with deliveries starting by the end of 2020,…
Contact tracing inside infected cells offer new clues about SARS-CoV-2 virus: Study
The findings of this research could lead to better diagnostics or new treatments, as well as helping to explain what makes this…
SII pauses trials of COVID-19 vaccine candidate Covishield in India
The company took this step after the DCGI issued a show cause notice to the company for not informing it about AstraZeneca…
Global pharma’s two battles – supply continuity and COVID-19 vaccine
Richa Mahindru, Domain Leader, Pharma and Life Sciences Practice, and Ishani Jain, Member, Pharma and Life Sciences Practice…
Informing payers and patients of biological therapy advantages can strengthen biosimilars market
Patients are unaware of the cost savings and payers are unclear if they can replace the reference biologics with the biosimilar…
Cipla Health forays into antifungal product category
Launches Clocip Clotrimazole Absorbent Dusting Powder and Clocip Clotrimazole Cream to treat fungal skin infections
DCGI instructs industry to follow defined pathways for application submission of rational FDCs
It gives six months to the manufacturers to submit the applications
DCGI issues notice to Serum Institute over AstraZeneca-Oxford COVID-19 vaccine trial suspension
If DCGI has any safety concerns, we will follow their instructions and abide by the standard protocol, said SII in response to…
GSK gets US FDA approval for Trelegy Ellipta to treat asthma, COPD
Trelegy is the first single inhaler triple therapy approved for the maintenance treatment of both asthma and COPD